Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.40 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CTSC | P53634 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29720299 | 0.95 | MME (0.39) | MMEPDCD1LG2CD274CA2CA1 | |
| SCHEMBL31265320 | 0.94 | NPSR1 (0.38) | MMECTSCSMN1; SMN2 | |
| SCHEMBL30122865 | 0.92 | MME (0.42) | MMEPDCD1LG2CD274CA2CA1 | |
| SCHEMBL30353283 | 0.85 | NPSR1 (0.41) | MMEPDCD1LG2CD274CA2CA1 | |
| SCHEMBL3396685 | 0.85 | NPSR1 (0.41) | MMEPDCD1LG2CD274CA2CA1 | |
| SCHEMBL3396676 | 0.85 | NPSR1 (0.41) | MMEPDCD1LG2CD274CA2CA1 | |
| SCHEMBL31064974 | 0.85 | NPSR1 (0.44) | MMECTSCSMN1; SMN2 | |
| SCHEMBL4968369 | 0.85 | NPSR1 (0.43) | MMECA2CA1CTSCSMN1; SMN2 | |
| SCHEMBL29531660 | 0.85 | NPSR1 (0.43) | MMECA2CA1CTSCSMN1; SMN2 | |
| SCHEMBL4968366 | 0.85 | NPSR1 (0.43) | MMECA2CA1CTSCSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240398939-A1 | ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES | SAGITTARIUS BIO, INC. | 2024-12-05 | — | — | US | claimed |
| EP-4404947-A1 | ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES | Sagittarius Bio, Inc. (US) | 2024-07-31 | — | — | EP | claimed |
| CN-118354779-A | Adenovirus and method of using adenovirus | 射手生物科技公司 | 2024-07-16 | — | — | CN | claimed |
| WO-2023049852-A1 | ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES | SAGITTARIUS BIO, INC. (US) | 2023-03-30 | — | — | WO | claimed |
| US-20240398939-A1 | ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES | SAGITTARIUS BIO, INC. | 2024-12-05 | — | — | US | disclosed |
| EP-4404947-A1 | ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES | Sagittarius Bio, Inc. (US) | 2024-07-31 | — | — | EP | disclosed |
| CN-118354779-A | Adenovirus and method of using adenovirus | 射手生物科技公司 | 2024-07-16 | — | — | CN | disclosed |
| WO-2023049852-A1 | ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES | SAGITTARIUS BIO, INC. (US) | 2023-03-30 | — | — | WO | disclosed |